Drug Profile
AI 401
Alternative Names: AI-401; Recombinant human insulin - AutoImmuneLatest Information Update: 09 Jun 2010
Price :
$50
*
At a glance
- Originator AutoImmune
- Developer AutoImmune; National Institute of Diabetes and Digestive and Kidney Diseases; University of Turku
- Class Insulins
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 21 May 2007 Phase-III clinical trials in Type-1 diabetes-mellitus prevention in Canada (PO)
- 21 May 2007 Phase-III clinical trials in Type-1 diabetes-mellitus prevention in Finland (Intranasal)
- 21 May 2007 Phase-III clinical trials in Type-1 diabetes-mellitus prevention in USA (PO)